{
  "drug_status": {
    "Zilovertamab Vedotin": "success",
    "Cyclophosphamide": "success",
    "Doxorubicin": "success",
    "Prednisone": "success",
    "Rituximab": "success"
  },
  "extractions": {
    "Zilovertamab Vedotin": {
      "drug_name": "Zilovertamab Vedotin",
      "drug_classes": [
        "Antibody Drug Conjugate",
        "ROR1-Targeted Antibody Drug Conjugate"
      ],
      "selected_sources": [
        "https://www.merck.com/news/mercks-investigational-zilovertamab-vedotin-at-1-75-mg-kg-dose-plus-standard-of-care-showed-promising-antitumor-activity-including-complete-response-rate-in-patients-with-relapsed-refractor/"
      ],
      "confidence_score": 1.0,
      "extraction_details": [
        {
          "extracted_text": "antibody drug conjugate (ADC)",
          "normalized_form": "Antibody Drug Conjugate",
          "class_type": "MoA",
          "evidence": "Zilovertamab vedotin is an investigational, potential first-in-class antibody drug conjugate (ADC)",
          "source": "https://www.merck.com/news/mercks-investigational-zilovertamab-vedotin-at-1-75-mg-kg-dose-plus-standard-of-care-showed-promising-antitumor-activity-including-complete-response-rate-in-patients-with-relapsed-refractor/",
          "rules_applied": [
            "Rule 26: Always capture Antibody Drug Conjugate",
            "Rule 38: Capture ADC in expanded form"
          ]
        },
        {
          "extracted_text": "ADC that targets receptor tyrosine kinase-like orphan receptor 1 (ROR1)",
          "normalized_form": "ROR1-Targeted Antibody Drug Conjugate",
          "class_type": "MoA",
          "evidence": "Zilovertamab vedotin is an investigational, potential first-in-class antibody drug conjugate (ADC) that targets receptor tyrosine kinase-like orphan receptor 1 (ROR1).",
          "source": "https://www.merck.com/news/mercks-investigational-zilovertamab-vedotin-at-1-75-mg-kg-dose-plus-standard-of-care-showed-promising-antitumor-activity-including-complete-response-rate-in-patients-with-relapsed-refractor/",
          "rules_applied": [
            "Rule 3: Maintain Title Case",
            "Rule 8: Hyphenate target and modality",
            "Rule 11: Include biological target",
            "Rule 38: Capture ADC in expanded form"
          ]
        }
      ],
      "extraction_method": "tavily",
      "reasoning": "The abstract title does not contain a drug class, so the search results were used. The Merck press release explicitly identifies Zilovertamab Vedotin as an 'antibody drug conjugate (ADC)' and specifies that it 'targets receptor tyrosine kinase-like orphan receptor 1 (ROR1)'. Following Rule 26 and Rule 38, ADC was expanded to 'Antibody Drug Conjugate'. Following Rule 11 and Rule 8, the target-specific class was formatted as 'ROR1-Targeted Antibody Drug Conjugate'.",
      "success": true
    },
    "Cyclophosphamide": {
      "drug_name": "Cyclophosphamide",
      "drug_classes": [
        "Alkylating Agent",
        "Antineoplastic Agent",
        "Antirheumatic Drug",
        "Immunosuppressive Agent",
        "Nitrogen Mustard"
      ],
      "selected_sources": [
        "https://www.ncbi.nlm.nih.gov/books/NBK553087/",
        "https://pubchem.ncbi.nlm.nih.gov/compound/Cyclophosphamide",
        "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212501s000lbl.pdf"
      ],
      "confidence_score": 1.0,
      "extraction_details": [
        {
          "extracted_text": "alkylating agent",
          "normalized_form": "Alkylating Agent",
          "class_type": "MoA",
          "evidence": "Cyclophosphamide is a phosphorodiamide that is 1,3,2-oxazaphosphinan-2-amine 2-oxide substituted by two 2-chloroethyl groups at the amino nitrogen atom. It has a role as a carcinogenic agent, an alkylating agent...",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Cyclophosphamide",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 5: Singular form",
            "Rule 21: Capture Agent as-is"
          ]
        },
        {
          "extracted_text": "nitrogen mustard",
          "normalized_form": "Nitrogen Mustard",
          "class_type": "Chemical",
          "evidence": "Cyclophosphamide is a nitrogen mustard that exerts its anti-neoplastic effects through alkylation.",
          "source": "https://www.ncbi.nlm.nih.gov/books/NBK553087/",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 7: Do not generalize subtype wording"
          ]
        },
        {
          "extracted_text": "immunosuppressive agent",
          "normalized_form": "Immunosuppressive Agent",
          "class_type": "Therapeutic",
          "evidence": "As an effective immunosuppressive agent, cyclophosphamide multiple studies have found cyclophosphamide useful in the treatment of autoimmune diseases...",
          "source": "https://www.ncbi.nlm.nih.gov/books/NBK553087/",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 21: Capture Agent as-is"
          ]
        },
        {
          "extracted_text": "antineoplastic agent",
          "normalized_form": "Antineoplastic Agent",
          "class_type": "Therapeutic",
          "evidence": "Used medicinally as an antineoplastic agent.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Cyclophosphamide",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 21: Capture Agent as-is"
          ]
        },
        {
          "extracted_text": "antirheumatic drug",
          "normalized_form": "Antirheumatic Drug",
          "class_type": "Therapeutic",
          "evidence": "It has a role as a carcinogenic agent, an alkylating agent, an immunosuppressive agent, an antineoplastic agent, an antirheumatic drug...",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Cyclophosphamide",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 5: Singular form"
          ]
        }
      ],
      "extraction_method": "tavily",
      "reasoning": "The abstract title does not contain drug classes, so extraction was performed from search results. Multiple sources (StatPearls, PubChem, and FDA labels) consistently identify Cyclophosphamide as an alkylating agent, nitrogen mustard, and immunosuppressive agent. PubChem specifically lists 'Antirheumatic Drug' and 'Antineoplastic Agent'. All terms were normalized to singular form and Title Case per rules.",
      "success": true
    },
    "Doxorubicin": {
      "drug_name": "Doxorubicin",
      "drug_classes": [
        "Anthracycline Antibiotic",
        "Anthracycline Topoisomerase Inhibitor",
        "Topoisomerase Inhibitor"
      ],
      "selected_sources": [
        "https://pubchem.ncbi.nlm.nih.gov/compound/Doxorubicin"
      ],
      "confidence_score": 1.0,
      "extraction_details": [
        {
          "extracted_text": "anthracycline antibiotic",
          "normalized_form": "Anthracycline Antibiotic",
          "class_type": "Chemical",
          "evidence": "Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius...",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Doxorubicin",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 5: Singular form",
            "Rule 7: Do not generalize subtype wording"
          ]
        },
        {
          "extracted_text": "Anthracycline Topoisomerase Inhibitor",
          "normalized_form": "Anthracycline Topoisomerase Inhibitor",
          "class_type": "MoA",
          "evidence": "Doxorubicin is an Anthracycline Topoisomerase Inhibitor.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Doxorubicin",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 13: Include Inhibitor term"
          ]
        },
        {
          "extracted_text": "Topoisomerase Inhibitor",
          "normalized_form": "Topoisomerase Inhibitor",
          "class_type": "MoA",
          "evidence": "The mechanism of action of doxorubicin is as a Topoisomerase Inhibitor.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Doxorubicin",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 13: Include Inhibitor term"
          ]
        }
      ],
      "extraction_method": "tavily",
      "reasoning": "The abstract title mentions the drug but does not provide a drug class. Therefore, search results were used. PubChem provides specific mechanism-based and chemical classes. 'Anthracycline Antibiotic' was extracted as a specific chemical/therapeutic class. 'Anthracycline Topoisomerase Inhibitor' and 'Topoisomerase Inhibitor' were extracted as MoA classes. Broad terms like 'Chemotherapeutic Agent' and 'Antineoplastic' were excluded per Rule 34.",
      "success": true
    },
    "Prednisone": {
      "drug_name": "Prednisone",
      "drug_classes": [
        "Glucocorticoid",
        "Corticosteroid",
        "Immunosuppressive Agent",
        "Anti-Inflammatory Drug",
        "Antineoplastic Agent",
        "Adrenergic Agent",
        "20-Oxo Steroid",
        "11-Oxo Steroid",
        "21-Hydroxy Steroid",
        "17alpha-Hydroxy Steroid",
        "3-Oxo-Delta(1),Delta(4)-Steroid",
        "Primary Alpha-Hydroxy Ketone",
        "Tertiary Alpha-Hydroxy Ketone",
        "C21-Steroid"
      ],
      "selected_sources": [
        "abstract_title",
        "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
        "https://www.ncbi.nlm.nih.gov/books/NBK534809/",
        "https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html",
        "https://www.drugs.com/tips/prednisone-patient-tips"
      ],
      "confidence_score": 1.0,
      "extraction_details": [
        {
          "extracted_text": "synthetic glucocorticoid",
          "normalized_form": "Glucocorticoid",
          "class_type": "MoA",
          "evidence": "Prednisone is a synthetic glucocorticoid drug",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 5: Singular form",
            "Rule 7: Do not generalize (Glucocorticoid)"
          ]
        },
        {
          "extracted_text": "corticosteroids",
          "normalized_form": "Corticosteroid",
          "class_type": "MoA",
          "evidence": "Prednisone is in a class of medications called corticosteroids.",
          "source": "https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 5: Singular form"
          ]
        },
        {
          "extracted_text": "immunosuppressive agent",
          "normalized_form": "Immunosuppressive Agent",
          "class_type": "Therapeutic",
          "evidence": "It has a role as a prodrug, an anti-inflammatory drug, an antineoplastic agent, an immunosuppressive agent and an adrenergic agent.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 21: Capture Agent as-is"
          ]
        },
        {
          "extracted_text": "anti-inflammatory drug",
          "normalized_form": "Anti-Inflammatory Drug",
          "class_type": "Therapeutic",
          "evidence": "It has a role as a prodrug, an anti-inflammatory drug...",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "antineoplastic agent",
          "normalized_form": "Antineoplastic Agent",
          "class_type": "Therapeutic",
          "evidence": "It has a role as ... an antineoplastic agent",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 21: Capture Agent as-is"
          ]
        },
        {
          "extracted_text": "adrenergic agent",
          "normalized_form": "Adrenergic Agent",
          "class_type": "MoA",
          "evidence": "It has a role as ... an adrenergic agent.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case",
            "Rule 21: Capture Agent as-is"
          ]
        },
        {
          "extracted_text": "20-oxo steroid",
          "normalized_form": "20-Oxo Steroid",
          "class_type": "Chemical",
          "evidence": "It is a 20-oxo steroid, an 11-oxo steroid, a 21-hydroxy steroid, a 17alpha-hydroxy steroid, a glucocorticoid, a 3-oxo-Delta(1),Delta(4)-steroid, a primary alpha-hydroxy ketone, a tertiary alpha-hydroxy ketone and a C21-steroid.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "11-oxo steroid",
          "normalized_form": "11-Oxo Steroid",
          "class_type": "Chemical",
          "evidence": "It is a ... 11-oxo steroid",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "21-hydroxy steroid",
          "normalized_form": "21-Hydroxy Steroid",
          "class_type": "Chemical",
          "evidence": "It is a ... 21-hydroxy steroid",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "17alpha-hydroxy steroid",
          "normalized_form": "17alpha-Hydroxy Steroid",
          "class_type": "Chemical",
          "evidence": "It is a ... 17alpha-hydroxy steroid",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "3-oxo-Delta(1),Delta(4)-steroid",
          "normalized_form": "3-Oxo-Delta(1),Delta(4)-Steroid",
          "class_type": "Chemical",
          "evidence": "It is a ... 3-oxo-Delta(1),Delta(4)-steroid",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "primary alpha-hydroxy ketone",
          "normalized_form": "Primary Alpha-Hydroxy Ketone",
          "class_type": "Chemical",
          "evidence": "It is a ... primary alpha-hydroxy ketone",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "tertiary alpha-hydroxy ketone",
          "normalized_form": "Tertiary Alpha-Hydroxy Ketone",
          "class_type": "Chemical",
          "evidence": "It is a ... tertiary alpha-hydroxy ketone",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        },
        {
          "extracted_text": "C21-steroid",
          "normalized_form": "C21-Steroid",
          "class_type": "Chemical",
          "evidence": "It is a ... C21-steroid.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone",
          "rules_applied": [
            "Rule 3: Apply Title Case"
          ]
        }
      ],
      "extraction_method": "tavily",
      "reasoning": "The abstract title mentions Prednisone as part of a regimen but does not provide a drug class, so Stage 2 extraction was performed. Multiple sources (PubChem, StatPearls, MedlinePlus, Drugs.com) consistently identify Prednisone as a Glucocorticoid and Corticosteroid. PubChem provides detailed chemical classifications (e.g., 20-Oxo Steroid) and therapeutic roles (e.g., Immunosuppressive Agent, Antineoplastic Agent). All terms were normalized to singular Title Case and hyphenated where required by the rules.",
      "success": true
    },
    "Rituximab": {
      "drug_name": "Rituximab",
      "drug_classes": [
        "CD20-Directed Antibody Interaction",
        "CD20-Directed Cytolytic Antibody",
        "CD20-Targeted Antibody",
        "CD20-Targeted Monoclonal Antibody"
      ],
      "selected_sources": [
        "abstract_text",
        "https://pubchem.ncbi.nlm.nih.gov/compound/Rituximab",
        "https://www.ncbi.nlm.nih.gov/books/NBK564374/"
      ],
      "confidence_score": 0.95,
      "extraction_details": [
        {
          "extracted_text": "CD20-directed Cytolytic Antibody",
          "normalized_form": "CD20-Directed Cytolytic Antibody",
          "class_type": "Therapeutic",
          "evidence": "Rituximab is a CD20-directed Cytolytic Antibody.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Rituximab",
          "rules_applied": [
            "Rule 3: Maintain Title Case",
            "Rule 5: Capture singular form",
            "Rule 7: Do not generalize subtype wording",
            "Rule 8: Hyphenate target and modality"
          ]
        },
        {
          "extracted_text": "CD20-directed Antibody Interaction",
          "normalized_form": "CD20-Directed Antibody Interaction",
          "class_type": "MoA",
          "evidence": "The mechanism of action of rituximab is as a CD20-directed Antibody Interaction.",
          "source": "https://pubchem.ncbi.nlm.nih.gov/compound/Rituximab",
          "rules_applied": [
            "Rule 3: Maintain Title Case",
            "Rule 8: Hyphenate target and modality"
          ]
        },
        {
          "extracted_text": "anti-CD20 monoclonal antibody",
          "normalized_form": "CD20-Targeted Monoclonal Antibody",
          "class_type": "MoA",
          "evidence": "rituximab, an anti-CD20 monoclonal antibody pivotal in treating various lymphoproliferative and autoimmune disorders.",
          "source": "https://www.ncbi.nlm.nih.gov/books/NBK564374/",
          "rules_applied": [
            "Rule 3: Maintain Title Case",
            "Rule 7: Do not generalize subtype wording",
            "Rule 9: Convert anti-X to X-Targeted"
          ]
        },
        {
          "extracted_text": "CD20-Targeted Antibody",
          "normalized_form": "CD20-Targeted Antibody",
          "class_type": "MoA",
          "evidence": "CD20-Targeted Antibody",
          "source": "abstract_text",
          "rules_applied": [
            "Rule 3: Maintain Title Case",
            "Rule 11: Include biological target",
            "Rule 31: Extract classes for component drugs in regimen"
          ]
        }
      ],
      "extraction_method": "tavily",
      "reasoning": "The abstract title did not contain a drug class, so extraction proceeded to the abstract text and search results. Multiple specific classes were identified including MoA and therapeutic types. Rules for Title Case, singular form, and target-modality hyphenation were applied. 'Anti-CD20' was converted to 'CD20-Targeted' per Rule 9.",
      "success": true
    }
  }
}